Xevant Announces Growth Investment with HCAP Partners

March 14, 2023 — Xevant, the leader and creator of automated data analytics for organizations managing pharmacy benefits, today announced the completion of a new investment round with HCAP Partners.

As the most comprehensive, independent pharmacy analytics platform available, Xevant offers pharmacy benefit managers, payers, hospitals, and consultants customized solutions with the ability to streamline decades-old analytic processes – ultimately resulting in lower drug costs and optimized performance and efficiencies. With this latest round of investment, the company will further expand its unique position to positively impact pharmacy benefit stakeholders and advance its long-held mission of revolutionizing healthcare services with its real-time automation platform.

Read the full release →

Previous
Previous

HCAP Partners Named an ImpactAssets 50 2023 Emeritus Impact Manager

Next
Next

BetterNight Raises $33M Growth Financing Round led by NewSpring